The aim of this study was therefore to identify miRNAs specifically targeting the mTOR pathway in lung neuroendocrine neoplasms as well as to validate their potential functional role as modulators of mTOR pharmacological inhibition. This evidence concerns the gene MTOR and medical procedure.